Literature DB >> 23115347

Grapheme-color synesthesia and posttraumatic stress disorder: preliminary results from the veterans health study.

Stuart N Hoffman1, Xiaopeng Zhang, Porat M Erlich, Joseph A Boscarino.   

Abstract

OBJECTIVE: Posttraumatic stress disorder (PTSD) is associated with altered neuropsychological function, possibly including complex visual information processing. Grapheme-color synesthesia refers to the phenomenon that a particular letter or number elicits the visual perception of a specific color. The study objective was to assess if grapheme-color synesthesia was associated with PTSD among US veterans.
METHOD: We surveyed 700 veterans who were outpatients in a multihospital system in Pennsylvania. All veterans had served at least one warzone deployment. PTSD and grapheme-color synesthesia were assessed using validated research instruments.
RESULTS: The mean age of veterans was 59 years, and 96% were men. The prevalence of current PTSD was 7% (95% confidence interval [CI] = 5.1-8.8), and current partial PTSD was 11% (95% CI = 9.3-14.0). The prevalence of current depression was 6% (95% CI = 4.7-8.3). Altogether, 6% (95% CI = 4.8-8.5) of veterans screened positive for grapheme-color synesthesia. Bivariate analyses suggested that grapheme-color synesthesia was associated with current PTSD (odds ratio [OR] = 3.4, p = .004) and current partial PTSD (OR = 2.4, p = .013), but not current depression (OR = 1.1, p = .91). Multivariate logistic regression results, adjusting for age, sex, marital status, level of education, current psychotropic medication use, and concussion history, confirmed these results.
CONCLUSIONS: Grapheme-color synesthesia seems to be associated with PTSD among veterans who had been deployed. This finding may have implications for PTSD diagnostic screening and treatment. Research is recommended to confirm this finding and to determine if synesthesia is a risk indicator for PTSD among nonveterans.

Entities:  

Mesh:

Year:  2012        PMID: 23115347      PMCID: PMC3556719          DOI: 10.1097/PSY.0b013e3182731007

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  33 in total

1.  Predicting Future PTSD using a Modified New York Risk Score: Implications for Patient Screening and Management.

Authors:  Joseph A Boscarino; H Lester Kirchner; Stuart N Hoffman; Jennifer Sartorius; Richard E Adams; Charles R Figley
Journal:  Minerva Psichiatr       Date:  2012-03

2.  Mental health service use 1-year after the World Trade Center disaster: implications for mental health care.

Authors:  Joseph A Boscarino; Richard E Adams; Charles R Figley
Journal:  Gen Hosp Psychiatry       Date:  2004 Sep-Oct       Impact factor: 3.238

3.  Increased structural connectivity in grapheme-color synesthesia.

Authors:  Romke Rouw; H Steven Scholte
Journal:  Nat Neurosci       Date:  2007-05-21       Impact factor: 24.884

4.  PTSD and alcohol use after the World Trade Center attacks: a longitudinal study.

Authors:  Joseph A Boscarino; H Lester Kirchner; Stuart N Hoffman; Jennifer Sartorius; Richard E Adams
Journal:  J Trauma Stress       Date:  2011-08-31

5.  Synesthesia, pseudo-synesthesia, and irritable bowel syndrome.

Authors:  Helen R Carruthers; Vivien Miller; Nicholas Tarrier; Peter J Whorwell
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

Review 6.  Genetics of posttraumatic stress disorder: Review and recommendations for future studies.

Authors:  Karestan C Koenen
Journal:  J Trauma Stress       Date:  2007-10

7.  PTSD onset and course following the World Trade Center disaster: findings and implications for future research.

Authors:  Joseph A Boscarino; Richard E Adams
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-03-07       Impact factor: 4.328

8.  Longitudinal determinants of posttraumatic stress in a population-based cohort study.

Authors:  Sandro Galea; Jennifer Ahern; Melissa Tracy; Alan Hubbard; Magdalena Cerda; Emily Goldmann; David Vlahov
Journal:  Epidemiology       Date:  2008-01       Impact factor: 4.822

9.  Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study.

Authors:  Murray B Stein; Kerry L Jang; Steven Taylor; Philip A Vernon; W John Livesley
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

10.  Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment.

Authors:  Joseph A Boscarino; Porat M Erlich; Stuart N Hoffman; Xiaopeng Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2012-03-23       Impact factor: 2.570

View more
  5 in total

1.  Synaesthesia: a distinct entity that is an emergent feature of adaptive neurocognitive differences.

Authors:  Jamie Ward
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-10-21       Impact factor: 6.237

2.  Social Support, Help-Seeking, and Mental Health Outcomes Among Veterans in Non-VA Facilities: Results from the Veterans' Health Study.

Authors:  Richard E Adams; Thomas G Urosevich; Stuart N Hoffman; H Lester Kirchner; Johanna C Hyacinthe; Charles R Figley; Joseph J Boscarino; Joseph A Boscarino
Journal:  Mil Behav Health       Date:  2017-05-19

3.  Mental Health Disorders and Treatment Seeking Among Veterans in Non-VA Facilities: Results and Implications from the Veterans' Health Study.

Authors:  Joseph A Boscarino; Stuart N Hoffman; James M Pitcavage; Thomas G Urosevich
Journal:  Mil Behav Health       Date:  2015

4.  Language evolution: examining the link between cross-modality and aggression through the lens of disorders.

Authors:  Antonio Benítez-Burraco; Ljiljana Progovac
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-03-22       Impact factor: 6.237

5.  Attitudes about Future Genetic Testing for Posttraumatic Stress Disorder and Addiction among Community-Based Veterans.

Authors:  Michelle R Lent; Stuart N Hoffman; H Lester Kirchner; Thomas G Urosevich; Joseph J Boscarino; Joseph A Boscarino
Journal:  Front Psychiatry       Date:  2017-05-15       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.